Objective-ATP-binding cassette transporter subfamily G member 2 (ABCG2), expressed in microvascular endothelial cells in the heart, has been suggested to regulate several tissue defense mechanisms. This study was performed to elucidate its role in pressure overload-induced cardiac hypertrophy. Methods and Results-Pressure overload was induced in 8-to 12-week-old wild-type and Abcg2 Ϫ/Ϫ mice by transverse aortic constriction (TAC). Abcg2 Ϫ/Ϫ mice showed exaggerated cardiac hypertrophy and ventricular remodeling after TAC compared with wild-type mice. In the early phase after TAC, functional impairment in angiogenesis and antioxidant response in myocardium was found in Abcg2 Ϫ/Ϫ mice. In vitro experiments demonstrated that ABCG2 regulates transport of glutathione, an important endogenous antioxidant, from microvascular endothelial cells. Besides, glutathione transported from microvascular endothelial cells in ABCG2-dependent manner ameliorated oxidative stress-induced cardiomyocyte hypertrophy. In vivo, glutathione levels in plasma and the heart were increased in wild-type mice but not in Abcg2 Ϫ/Ϫ mice after TAC. Treatment with the superoxide dismutase mimetic ameliorated cardiac hypertrophy in Abcg2 Ϫ/Ϫ mice after TAC to the same extent as that in wild-type mice, although cardiac dysfunction with impaired angiogenesis was observed in Abcg2 Ϫ/Ϫ mice. Conclusion-ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response. 
C
ardiac hypertrophy is an abnormal increase in the volume of the heart muscle resulting from an increase in the size of individual cardiomyocytes and proliferation of noncardiomyocyte cells in response to increased workload. Although cardiac hypertrophy is initially an adaptive response to maintain cardiac function, prolonged cardiac hypertrophy is detrimental and leads to heart failure, which is associated with high mortality. [1] [2] [3] Therefore, it is important to prevent the development of cardiac hypertrophy.
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ATP-binding cassette transporter subfamily G member 2 (ABCG2), also known as breast cancer resistant protein, is a transmembrane transporter protein fueled by ATP hydrolysis. 4 This protein was originally identified in tumor cells for its ability to confer drug resistance by active effluxion of multiple anticancer drugs. 5 Recently, ABCG2 has been shown to be expressed in various normal organs, 6 and it has been suggested to have physiological functions in addition to drug effluxion. Several signaling molecules regulate transcription of ABCG2, including peroxisome proliferator-activated receptor ␥, protein kinase B, hypoxiainducible factor-2␣, and nuclear factor erythroid-2 related factor 2. [7] [8] [9] [10] These molecules play important roles in angiogenesis and protection against oxidative stress, and thus, it is suggested that ABCG2 may be associated with angiogenesis and redox regulation in tissues under pathological conditions. In fact, it was reported that ABCG2 may relieve oxidative stress and inflammatory response in brain tissues and may play a protective role in Alzheimer disease. 11 In the heart, we previously demonstrated that ABCG2 is expressed mainly in endothelial cells of mi-crovessels and plays a pivotal role in cardiac repair after myocardial infarction by promoting angiogenesis. 12 These findings suggest that ABCG2 may be important for tissue defense in various diseases. In the present study, we explored the role of ABCG2 in pressure overload-induced cardiac hypertrophy and subsequent heart failure.
Methods
Detailed methods can be found in the online-only Data Supplement.
Experimental Model of Pressure Overload-Induced Cardiac Hypertrophy
Eight-to 12-week-old male wild-type (WT) FVB/NJcl mice (CLEA Japan, Hamamatsu, Japan) and Abcg2 Ϫ/Ϫ mice (Taconic, Hudson, NY, FVB/N background, model number 2767-M) were used. 13 Pressure overload was induced by transverse aortic constriction (TAC) as described previously. 14 
Cell Cultures
Human microvascular endothelial cells from the heart (HMVEC-Cs) were purchased from Lonza (Basel, Switzerland). Cardiomyocytes were prepared from neonatal rats and cultured as described previously with minor modifications. 15 
Statistical Analysis
Data are shown as meanϮSEM. Values of PϽ0.05 were considered statistically significant.
Results

Impact of Genetic Disruption of ABCG2 on Pressure Overload-Induced Cardiac Hypertrophy
We previously reported that ABCG2 is expressed mainly in the endothelial cells of microvessels in the heart. 12 We found that during pressure overload, ABCG2 mRNA and protein expression levels were upregulated in the heart ( Figure I in the online-only Data Supplement). To determine the impact of ABCG2 deficiency on cardiac hypertrophy and subsequent heart failure, we subjected WT and Abcg2 Ϫ/Ϫ mice to pressure overload by TAC. The survival rate up to 28 days after TAC was significantly lower in Abcg2 Ϫ/Ϫ mice than in WT mice (Abcg2 Ϫ/Ϫ mice, 46.8%, nϭ62, versus WT mice, 78.8%, nϭ33, Pϭ0.002) ( Figure 1A ), whereas all shamoperated WT and Abcg2 Ϫ/Ϫ mice survived until 28 days after TAC (nϭ11 for each group). Most of the deaths in Abcg2 Ϫ/Ϫ mice occurred at 4 days after TAC. Dead mice displayed pulmonary congestion, which suggested that they died of congestive heart failure rather than arrhythmia ( Figure II in the online-only Data Supplement).
Whereas the baseline heart weight to body weight ratio was not different between WT and Abcg2 Ϫ/Ϫ mice, Abcg2
Ϫ/Ϫ mice showed exaggerated myocardial growth at 4 and 28 days after TAC compared with WT mice ( Figure 1B ). Left ventricular (LV) dimensions and function, examined using echocardiography, were similar in WT and Abcg2 Ϫ/Ϫ mice before TAC ( Figure 1C ). WT mice showed concentric hypertrophy at 4 days after TAC and ventricular dilatation with further hypertrophy at 28 days after TAC. In Abcg2 Ϫ/Ϫ mice, greater concentric hypertrophy with augmented ejection fraction was observed at 4 days after TAC compared with WT mice. Besides, at 28 days after TAC, Abcg2 Ϫ/Ϫ mice showed greater ventricular dilatation with impaired systolic function compared with WT mice. Hemodynamic measurement revealed higher LV end-diastolic pressure after TAC in Abcg2 Ϫ/Ϫ mice than in WT mice, although LV end-diastolic pressure at baseline did not differ between the 2 groups ( Figure 1D ). In addition, maximum ϩdp/dt and minimum -dp/dt were worse in Abcg2 Ϫ/Ϫ mice than in WT mice at 28 days after TAC. Histological assessment with hematoxylin and eosin (H&E) and Sirius Red staining demonstrated significantly larger cardiomyocytes and exaggerated cardiac fibrosis after TAC in Abcg2 Ϫ/Ϫ mice compared with those in WT mice, whereas there was no significant difference in the size of cardiomyocytes or the extent of cardiac fibrosis at baseline between WT and Abcg2 Ϫ/Ϫ mice ( Figure IIIA and IIIB in the online-only Data Supplement). Consistently, expression levels of hypertrophic marker genes, such as atrial natriuretic factor and B-type natriuretic peptide, and fibrosisrelated genes, such as collagen type 1, ␣1 and collagen type 3, ␣1, were higher in Abcg2 Ϫ/Ϫ mice than in WT mice after TAC ( Figure IIIC and IIID in the online-only Data Supplement). We also measured gene expression levels of transforming growth factor-␤1 (TGF-␤1) and fibronectin, but no significant difference was found between WT and Abcg2 mice except higher expression of fibronectin in Abcg2 Ϫ/Ϫ mice at 4 days after TAC. Echocardiographic, hemodynamic, and histological data showed no significant difference between WT and Abcg2 Ϫ/Ϫ mice subjected to sham operation (Table I in the online-only Data Supplement).
Taken together, these results indicate that ABCG2 deficiency leads to exaggerated hypertrophic response and ventricular remodeling during pressure overload, which results in decompensated heart failure. Therefore, our results suggest that ABCG2 plays a protective role in pressure overloadinduced cardiac hypertrophy.
ABCG2 Deficiency Impairs Angiogenesis During Pressure Overload
Previous reports indicated that angiogenesis contributes to the pathogenesis of cardiac hypertrophy and heart failure. 16 -18 ABCG2 expression in the endothelial cells of microvessels suggests that ABCG2 may play a significant role in angiogenesis. In fact, we previously demonstrated that ABCG2 regulates survival, migration, and tube formation of microvascular endothelial cells. 12 Immunohistochemistry with anti-CD31 antibody demonstrated that capillary density and the number of capillaries per cardiomyocyte were increased after TAC in WT mice ( Figure 2A ). Abcg2 Ϫ/Ϫ mice showed reduced capillary density and a smaller number of capillaries per cardiomyocyte at 4 and 28 days after TAC compared with WT mice. To assess whether impaired angiogenesis after TAC in Abcg2 Ϫ/Ϫ mice was a secondary effect due to ABCG2 deficiency in other organs such as the kidney and the liver, in which ABCG2 is abundantly expressed, we subjected WT and Abcg2 Ϫ/Ϫ mice to hindlimb ischemia ( Figure IV in the online-only Data Supplement ). This experiment demonstrated no significant differences in angiogenesis after hindlimb ischemia between WT and Abcg2 Ϫ/Ϫ mice, which suggests that ABCG2 expression in the heart itself is important for angiogenesis after TAC.
At 4 days after TAC, expression levels of angiogenesisrelated genes, such as hypoxia-inducible factor-1␣, hypoxiainducible factor-2␣, vascular endothelial growth factor A, and angiopoietin-1, were comparable or higher in Abcg2 Ϫ/Ϫ mice than in WT mice, whereas expression of these genes was comparable or reduced in Abcg2 Ϫ/Ϫ mice compared with WT mice at 28 days after TAC ( Figure 2B ). These results suggest that impaired angiogenesis after TAC in Abcg2 Ϫ/Ϫ mice might result from different mechanisms in the early phase with concentric hypertrophy and in the chronic phase with maladaptive hypertrophy during pressure overload. In the early phase of pressure overload, impaired angiogenesis in Abcg2 Ϫ/Ϫ mice might be attributable to impairment of endothelial cell survival and function by ABCG2 deficiency, 12 which might lead to compensatory increase in angiogenic signals. On the other hand, in the chronic phase, in addition to functional impairment of endothelial cells, suppression of angiogenic signals might contribute to reduced capillary density in Abcg2 Ϫ/Ϫ mice. In fact, the expression of the tumor suppressor p53, accumulation of which has been reported to lead to inhibition of angiogenic signals, 18, 19 was upregulated at 4 days after TAC in Abcg2 Ϫ/Ϫ mice and remained elevated at 28 days after TAC, whereas in WT mice, p53 expression was not increased at 4 days after TAC (Figure V in the online-only Data Supplement).
ABCG2 Deficiency Exacerbates Oxidative Stress and Inflammation During Pressure Overload
ABCG2 has been suggested to regulate redox balance and inflammatory response in tissues. 9, 11 Because oxidative stress and inflammation has been reported to play an important role in the pathogenesis of cardiac hypertrophy and heart failure, 20 -22 we assessed oxidative stress and inflammatory response during pressure overload.
To investigate oxidative stress in the heart, we assessed lipid peroxidation and protein oxidation in the myocardial tissues. 12 We found that oxidative stress in the heart gradually increased during pressure overload in WT mice ( Figure 3A and 3B). Whereas oxidative stress in the heart was not different between WT and Abcg2 Ϫ/Ϫ mice at baseline, exaggerated oxidative stress was found in Abcg2 Ϫ/Ϫ mice compared with that in WT mice at 4 days after TAC. At 28 days after TAC, oxidative stress in the hearts of Abcg2 Ϫ/Ϫ mice remained higher than that at baseline. To assess reactive oxygen species production and antioxidant response in the heart, we quantified mRNA expression of reactive oxygen species production-related genes and antioxidant genes by real-time polymerase chain reaction ( Figure 3C and 3D ). There was no significant difference in the expression of these genes at baseline between WT and Abcg2 Ϫ/Ϫ mice. At 4 days after TAC, no significant differences were found in the expression of reactive oxygen species production-related genes, such as the nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, xanthine oxidase, and nitric oxide synthase between WT and Abcg2 Ϫ/Ϫ mice, although at 28 days after TAC, the expression level of NADPH oxidase 4 was higher in Abcg2 Ϫ/Ϫ mice than in WT mice. Expression of antioxidant genes, such as nuclear factor erythroid-2 related factor 2, superoxide dismutases, ␥-glutamylcysteine synthase, glutathione peroxidase, catalase, and thioredoxins, was comparable or higher in Abcg2 Ϫ/Ϫ mice than in WT mice at 4 days after TAC, whereas expression levels of these genes were comparable or lower in Abcg2 Ϫ/Ϫ mice than in WT mice at 28 days after TAC. These results suggest that exaggerated oxidative stress in Abcg2 Ϫ/Ϫ mice at 4 days after TAC may be attributable to functional impairment in antioxidant response in the heart, which might result in a compensatory increase in expression levels of antioxidant genes.
To investigate inflammatory response during pressure overload, we measured mRNA expression levels of proinflammatory cytokines, such as tumor necrosis factor-␣, interleukin-6, and monocyte chemotactic protein-1 ( Figure   VIA in the online-only Data Supplement). In the early phase of pressure overload, expression levels of those cytokines were elevated in WT mice and were further upregulated in Abcg2 Ϫ/Ϫ mice compared with WT mice. Immunohistochemistry with anti-Mac-3 antibody demonstrated more macrophage infiltration in Abcg2 Ϫ/Ϫ mice than in WT mice at 4 days after TAC ( Figure VIB in the online-only Data Supplement). These results suggest that exaggerated inflammatory response in the early phase of pressure overload might contribute to deteriorated prognosis of Abcg2 Ϫ/Ϫ mice subjected to TAC.
ABCG2 Regulates Extracellular Concentrations of Glutathione in Microvascular Endothelial Cells of the Heart In Vitro
Our results of in vivo experiments suggested that ABCG2 may play an important role in antioxidant response in the heart. In the previous studies, ABCG2 was reported to transport glutathione, an important endogenous antioxidant. 23 In fact, in WT mice, glutathione peroxidase was highly upregulated in the early phase after TAC ( Figure 3D ). Thus, we hypothesized that glutathione might be one of the key players in antioxidant response in the early phase during pressure overload. To examine whether ABCG2 is involved in glutathione transport in microvascular endothelial cells of the heart, we measured extracellular and intracellular glutathione concentrations in HMVEC-Cs. Without stimulation of glutathione transport, extracellular and intracellular glutathione levels in HMVEC-Cs treated with fumitremorgin C (FTC), a specific inhibitor of ABCG2, or ABCG2 small interfering RNA were not different from those in HMVEC-Cs treated with vehicle or control small interfering RNA ( Figure 4A-4E ). When we stimulated glutathione transport with 25mol/L 2Ј,5Ј-dihydroxychalcone (2Ј,5Ј-DHC), 24 ABCG2 inhibition suppressed an increase of extracellular glutathione concentrations in HMVEC-Cs, whereas intracellular glutathione levels were not altered by FTC or ABCG2 small interfering RNA. These results indicate that ABCG2 regulates extracellular glutathione levels in microvascular endothelial cells under stimulated conditions.
ABCG2 Regulates Glutathione Levels In Vivo
To assess the impact of ABCG2 expression on glutathione levels in vivo, we measured glutathione levels in plasma and the heart in WT and Abcg2 Ϫ/Ϫ mice ( Figure 4F ). There were no significant differences in glutathione levels in plasma and the heart between WT and Abcg2 Ϫ/Ϫ mice at baseline or after sham operation. In WT mice, plasma glutathione levels were increased after TAC, whereas in Abcg2 Ϫ/Ϫ mice, plasma glutathione levels after TAC were similar to those at baseline or after sham operation. This finding suggests that ABCG2 may play an important role in the regulation of glutathione levels in extracellular space also in vivo under pathological conditions. As glutathione levels in the heart were increased after TAC in WT mice but not in Abcg2 Ϫ/Ϫ mice, lack of glutathione might contribute to exaggerated oxidative stress in the myocardial tissues in Abcg2 Ϫ/Ϫ mice during pressure overload. In fact, in WT (KO) mice. C, Reactive oxygen species production-related gene expression. Expression of NADPH oxidase 2 (NOX2), NADPH oxidase 4 (NOX4), xanthine oxidase (XO), and nitric oxide synthase 3 (NOS3) was assessed by real-time polymerase chain reaction (PCR) (nϭ4 for each group). D, Antioxidant gene expression. Expression of nuclear factor erythroid-2 related factor 2 (Nrf2), superoxide dismutase 1 (SOD1), SOD2, SOD3, ␥-glutamylcysteine synthase (␥-GCS), glutathione peroxidase 1 (GPx1), catalase, thioredoxin 1 (Trx1), and Trx2 was quantified by real-time PCR (nϭ4 for each group). Open columns indicate WT mice; filled columns, KO mice; B, baseline; D4, 4 days after TAC; D28, 28 days after TAC. *PϽ0.05 vs WT mice at baseline; †PϽ0.05 vs KO mice at baseline; ‡PϽ0.05 vs WT mice at the same postoperative day.
mice, the ratios of total glutathione to oxidized glutathione in plasma and the heart were decreased after TAC compared with those at baseline or after sham operation ( Figure VII in the online-only Data Supplement), which indicates that glutathione is involved in antioxidant response during pressure overload. Total glutathione to oxidized glutathione ratios were more decreased in Abcg2 Ϫ/Ϫ mice than in WT mice after TAC both in plasma and in the heart. This might result from the lack of glutathione supply in Abcg2 Ϫ/Ϫ mice.
Glutathione Transported From Microvascular Endothelial Cells in ABCG2-Dependent Manner Ameliorates Oxidative Stress-Induced Cardiomyocyte Hypertrophy
To investigate the role of glutathione transport mediated by ABCG2 in the pathophysiology of cardiac hypertrophy, we assessed the effect of the medium conditioned by HMVEC-Cs with stimulation of glutathione transport on oxidative stress-induced cardiomyocyte hypertrophy in vitro ( Figure 4G ). Without oxidative stress, cell surface areas of isolated cardiomyocytes cultured in HMVEC-C-conditioned medium treated with FTC were similar to those treated with vehicle, whether or not glutathione transport in HMVEC-Cs was stimulated by 2Ј5Ј-DHC. Oxidative stress with 30 mol/L hydrogen peroxide induced hypertrophy in isolated cardiomyocytes. Without FTC treatment, the medium conditioned by HMVEC-Cs with stimulation of glutathione transport by 2Ј,5Ј-DHC ameliorated oxidative stress-induced cardiomyocyte hypertrophy. However, with FTC treatment, 2Ј,5Ј-DHC-treated conditioned medium failed to exert this effect. These results indicate that glutathione transport mediated by ABCG2 from microvascular endothelial cells may play an important role in the pathophysiology of cardiac hypertrophy through its antioxidant effect.
Oxidative Stress Plays a Critical Role in the Phenotype of Abcg2 ؊/؊ Mice Subjected to Pressure Overload
Our results of in vitro and in vivo experiments suggested that antioxidant response mediated by ABCG2 may be critically involved in the pathophysiology of cardiac hypertrophy. To assess the impact of oxidative stress on the phenotype of Abcg2 Ϫ/Ϫ mice after TAC, we performed a rescue experiment by using a superoxide dismutase mimetic, manganese 5,10,15,20-tetrakis-(4-benzoic acid) porphyrin (MnTBAP). Phosphate-buffered saline (PBS) treatment did not affect the response to pressure overload in WT and Abcg2 Ϫ/Ϫ mice. After sham operation, we could not find any difference between WT and Abcg2 Ϫ/Ϫ mice with MnTBAP treatment. However, treatment with MnTBAP improved the survival rate of Abcg2 Ϫ/Ϫ mice after TAC ( Figure 5A ). Exaggerated myocardial growth after TAC in Abcg2 Ϫ/Ϫ mice was also reversed to the same extent as that in WT mice by MnTBAP treatment ( Figure 5B ). Echocardiography demonstrated that MnTBAP ameliorated concentric hypertrophy at 4 days after TAC in Abcg2 Ϫ/Ϫ mice to the same extent as that in WT mice ( Figure VIII in the online-only Data Supplement). At 28 days after TAC, under MnTBAP treatment, LV wall thickness in Abcg2 Ϫ/Ϫ mice was similar to that in WT mice ( Figure 5C ). MnTBAP also improved LV size and systolic function after TAC in Abcg2 Ϫ/Ϫ mice, although these parameters were not ameliorated to the same extent as those in WT mice. Hemodynamic measurement revealed that treatment with MnTBAP improved LV end-diastolic pressure at 28 days after TAC in Abcg2 Ϫ/Ϫ mice, although LV end-diastolic pressure remained 
higher in Abcg2
Ϫ/Ϫ mice than in WT mice under MnTBAP treatment ( Figure IX in the online-only Data Supplement). With MnTBAP treatment, maximum ϩdp/dt and minimum -dp/dt in Abcg2 Ϫ/Ϫ mice were similar to those in WT mice at 28 days after TAC. Histological assessment with H&E and Sirius Red staining demonstrated that MnTBAP ameliorated cardiomyocyte hypertrophy and interstitial fibrosis after TAC in Abcg2 Ϫ/Ϫ mice to the same extent as those in WT mice ( Figure 5D and Figure X in the online-only Data Supplement). These results indicate that oxidative stress plays a critical role in the phenotype of Abcg2 Ϫ/Ϫ mice after TAC, and thus, antioxidant response mediated by ABCG2 is essential for the protection of the heart against pressure overload.
We also assessed angiogenesis and inflammatory response after TAC by immunohistochemistry with anti-CD31 and anti-Mac-3 antibodies. Capillary density and the number of capillaries per cardiomyocyte after TAC in Abcg2 Ϫ/Ϫ mice remained reduced compared with those in WT mice even under treatment with MnTBAP ( Figure 5E and Figure 
Discussion
In the present study, we found that genetic disruption of ABCG2 deteriorated pressure overload-induced cardiac hypertrophy and ventricular remodeling in mice. Abcg2 Ϫ/Ϫ mice showed impaired angiogenesis and antioxidant response in myocardium in the early phase of pressure overload. We previously showed that ABCG2 plays a pivotal role in angiogenesis in the heart via modulation of survival and function of microvascular endothelial cells. 12 In the present study, we also revealed that ABCG2 plays an important role in antioxidant response in the heart, at least in part, through regulation of glutathione transport from microvascular endothelial cells.
It has been shown that a mismatch between the number of capillaries and the size of cardiomyocytes occurs during the development of cardiac hypertrophy, resulting in myocardial hypoxia. 17, 25, 26 Insufficient angiogenic response to myocardial hypoxia has been reported to lead to cardiac dysfunction. 18 In the present study, impaired angiogenesis due to ABCG2 deficiency might lead to exacerbated myocardial hypoxia during pressure overload and might contribute to poor outcomes after TAC in Abcg2 Ϫ/Ϫ mice. In fact, under MnTBAP treatment, Abcg2 Ϫ/Ϫ mice, in which angiogenesis was impaired, showed more LV dilatation and impaired cardiac function after TAC compared with WT mice, although cardiomyocyte hypertrophy and interstitial fibrosis were similar between WT and Abcg2 Ϫ/Ϫ mice. Thus, ABCG2-mediated angiogenesis may play an important role in cardioprotection against pressure overload.
In our previous study, we showed that ABCG2 plays an important role in survival of microvascular endothelial cells of the heart under oxidative stress, at least in part, by preventing from accumulation of intracellular protoporphyrin .05 for the log-rank test. B, Heart weight (HW) to body weight (BW) ratios at 28 days after the operation (nϭ5 for each group). C, Echocardiographic data at 28 days after the operation (nϭ5 for each group). LVEDD, left ventricular end-diastolic diameter; IVSth, interventricular septum thickness; LVPWth, LV posterior wall thickness. D, Cardiomyocyte hypertrophy and cardiac fibrosis at 28 days after the operation (nϭ5 for each group). CSA indicates cross-sectional area; CVF, collagen volume fraction. E, Capillary density and the number of capillaries per cardiomyocyte at 28 days after the operation (nϭ3 for sham; nϭ4 for TAC). Open columns indicate WT mice; filled columns, KO mice; W, WT mice; K, KO mice; P, PBS group; M, MnTBAP group. *PϽ0.05 vs sham; †PϽ0.05 vs WT mice with the same treatment; ‡PϽ0.05 vs PBS group after the same operation.
IX. 12 The current study suggests that glutathione transport may also contribute to the protective effect of ABCG2 against oxidative stress in microvascular endothelial cells. In this study, angiogenesis remained impaired in Abcg2 Ϫ/Ϫ mice even under MnTBAP treatment after TAC. This result indicates that ABCG2 may regulate angiogenesis not only through its antioxidant effect but also through other mechanisms. Our previous report suggested that ABCG2 may be involved in chemotaxis of microvascular endothelial cells. 12 In fact, sphingosine-1-phosphate, a bioactive lipid mediator of chemotaxis, 27, 28 was reported to be a substrate of ABCG2. 29 Collectively, ABCG2 may promote angiogenesis in the heart by transporting several substrates that are essential for survival and function of microvascular endothelial cells. Additional studies will be needed to elucidate the detailed roles of ABCG2 in angiogenesis in the heart under pathological conditions.
It is firmly established that oxidative stress plays a causative role in the pathogenesis of cardiac hypertrophy and heart failure. 20, 21 Oxidative stress can induce cardiomyocyte hypertrophy, interstitial fibrosis, inflammatory response, contractile dysfunction, and apoptosis. In the present study, we demonstrated that exaggerated oxidative stress induced severe cardiac hypertrophy despite insufficient angiogenesis in Abcg2 Ϫ/Ϫ mice, which might lead to high mortality in the early phase of pressure overload due to diastolic heart failure with preserved systolic function. Besides, oxidative stress contributed to exacerbated ventricular remodeling in the chronic phase of pressure overload in Abcg2 Ϫ/Ϫ mice. Thus, our results indicate that antioxidant response mediated by ABCG2 is critically involved in cardioprotection against pressure overload.
Glutathione is an antioxidant tripeptide that is maintained at millimolar concentrations within the cell. Although several glutathione transporters have been identified, 30 -32 our results indicate that ABCG2 is essential for the regulation of extracellular glutathione concentrations under pathological conditions in the heart. In the present study, we showed that glutathione transport from microvascular endothelial cells contributes to the antioxidant effect mediated by ABCG2. Besides, glutathione is also important in many signaling processes, including immune responses, 33 and thus, ABCG2 may be one of the key players in inflammatory response in the heart. In summary, our findings reveal a previously unrecognized role of ABCG2 in pressure overload-induced cardiac hypertrophy and subsequent heart failure. ABCG2 may have a therapeutic potential for hypertrophic heart disease by promoting angiogenesis and relieving oxidative stress in the heart. Moreover, it may be plausible that mutation or singlenucleotide polymorphism in ABCG2 gene might influence prognosis of patients with cardiac hypertrophy. 34, 35 
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